Medullary sponge kidney: unusual finding in kidney transplant recipient

Medullary sponge kidney (MSK) is a kidney malformation that normally occurs in one of the numerous steps characterizing renal morphogenesis. Abnormalities in genes fundamental for renal formation lead to diminished distal nephron development, causing cyst formation, nephrocalcinosis and distal renal tubular acidosis as subsequent consequence of urine concentration defects [1]. Dilatation of the collecting ducts in the renal medulla or in renal papillae produce the spongy appearance for which the disease is named [2]. MSK is generally considered a sporadic disorder, but an apparently autosomal dominant inheritance has also been observed. The disease affects both genders, with a slight female prevalence, and is generally diagnosed in adulthood (20–30 years old). Clinical manifestations include nephrolithiasis, urinary tract infections, micro- or macro-hematuria, hypercalciuria and hypocitraturia, but it is worth saying that often it may be asymptomatic and it is diagnosed as an incidental finding during diagnostic follow-up [3]. When it becomes manifest in children, the disease is more severe and is accompanied by rickets-like symptoms. Recurrent calcium nephrolithiasis and nephrocalcinosis are the most common signs, hyperparathyroidism is frequently associated.

Although the pathogenesis of MSK is yet to be determined, the idea that it is a developmental disorder is supported by its association with different malformative conditions (Wilms tumor, Horse-shoe kidney, autosomal dominant polycystic kidney disease, other urinary tract malformations) especially with Beckwith–Wiedemann syndrome [4, 5].

The diagnosis of MSK is made through intravenous urography (gold standard), but nowadays it has almost been replaced by computed tomography urography (CTU) even though it did not present the same sensibility. Concerning ultrasound, MSK presents a peculiar tetrad: hypoechoic medullary areas, hyperechoic spots, microcystic dilatations of papillary zone and multiple calcifications (linear, small stones or calcified intracystic sediment) in each papilla that, added to laboratory data and clinical history, could be helpful to identify patients with MSK [6]. Though differential diagnosis for cystic renal disease in “young kidneys” is very challenging, Thomas et al. proposed a pragmatic reporting format for cystic renal diseases [7]. The most common differential diagnosis are with nephronophthisis (NPH) and/or medullary cystic kidney disease (ADTKD). In NPH, kidneys are small to normal in size, with increased echogenicity, reduced cortico-medullary differentiation, and renal cysts formation on the cortico-medullary border. In ADTKD, kidneys are normal to small in size, with multiple cysts at the cortico-medullary junction and sometimes in the renal medulla, but renal stones and microcalcifications are not usually detected in these cases [8].

Aside from recurrent episodes of nephrolithiasis, MSK can be considered a benign condition. Most treatment regimens are centered around prophylactic measures compared to symptomatic care and a proper therapy for stones formations [9]. Considering organ shortages, Cheungpasitporn W and colleagues aimed to assess the outcomes of living kidney donors with MSK, reporting the safety of MSK kidney donors with normal kidney function, low kidney stone risk and no significant comorbidity [10].

We present a case of a 45-year-old female, who received a double-kidney transplantation 29 years before our evaluation. She came to our attention in the context of her normal transplant follow-up. Medical history reported in 1983 diagnosis of nephronophthisis, 1990 peritoneal dialysis, 1991 total parathyroidectomy for severe hyperparathyroidism, 1991 double renal transplantation, 2002 tibia’s bone dystrophy. The patient reports several urinary tract infections in the last 2 years, and several episodes of vague loin pain without a radiological or biochemical correlation. In the latest sonographies, was reported that kidneys presented millimetrical hyperechoic spots and multiple calcifications in transplanted organs.

Laboratory findings: renal function was normal (creatinine 0,91 mg/dl, BUN 32 mg/dl, eGFR 84 ml/min), calcium 9,1 mg/dl, parathormone (PTH) was undetectable, calciuria and citraturia were normal, no bacterial were founded in urine or blood.

We performed abdomen ultrasound that showed wrinkled native kidneys, though transplanted kidneys were localized both in the right iliac fossa, presented normal size (10 cm and 9,5 cm), cortical diameter was normal (14 mm and 15 mm), diffuse hyperechoic medullary (Fig. 1) with some hypoechoic areas (consistent with microcystic dilatation of papillary zone), several diffuse millimetrical hyperechoic spots (from 1–2 mm to 7 mm) in each papillae, consistent with calcifications (Figs. 2 and 3). The cranial transplanted kidney shown a second degree hydronephrosis in the context of replenish bladder, without distal obstructions (Fig. 1b).

Ultrasound findings are consistent with medullary sponge kidney in the transplanted kidneys.

Curiously, the transplanted kidneys came from a newborn (< 1 year) and the size mismatch obliged the clinicians to perform a double-kidney transplantation, in order to guarantee satisfactory renal function.

The patient complained of loin pain and often about dysuria, she presented normal renal function and no urine abnormalities. Sonography is highly suggestive of MSK, but finding this anomaly in transplanted kidneys is something really rare. Considering the long story of kidney transplant, it could not be ethically proposed to perform UroCT in a patient with normal renal function, due to the high potential risk of contrast-induced nephropathy, and according to a few studies, magnetic resonance (MR) is not sensitive enough to disclose the typical signs of MSK. Considering that the donor was a newborn, it would have been difficult to detect those kind of alterations at the moment of transplantation, therefore it is technically possible that this female inherited two kidneys with these anomalies. To our knowledge, no cases of double transplantation with MSK in a deceased donor have been previously reported. There may be several explanation: first, the low prevalence of the disease; second, the long-term presentation of the disease that normally exceeds transplant survival; third, the mostly asymptomatic course of the disease; fourth, the paucisymptomatic course of kidney stones in the transplanted kidney; last, the difficulty to detect this kind of disease.

MSK is a rare genetic kidney disease that remains paucisymptomatic for a long time, though it could have been found in a kidney transplantation. It is at risk of being underdiagnosed in the near future because urography is less and less used in the diagnostic work-up, but sonography supported by clinics, history and biochemical analysis could help establish the diagnosis of MSK.